AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Biolevate raises €30M Series A led by RAISE France and Orange Ventures to scale life sciences AI platform for automating scientific and regulatory workflows.
PRIVATESep 22, 2026•about 2 hours ago
Amount Raised
€30 Million
Round Type
Series A
ParisArtificial IntelligenceMachine LearningNatural Language Processing
Investors
Eqt VenturesStation FMsd Global Health Innovation FundOrange VenturesRaise France
Description
Biolevate, a Paris-based life sciences AI company founded by former Dataiku engineers, has raised €30 million in Series A funding to expand its enterprise agentic AI platform. The round was co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures. The platform automates scientific and regulatory workflows across drug discovery, clinical trials, and regulatory compliance while maintaining human oversight in regulated environments. Biolevate now serves over a dozen enterprise customers and has achieved a 16x acceleration in literature reviews and 80% efficiency gains in regulatory intelligence.
Company Information
Company
Biolevate
Location
Paris, Ile-de-France, France
About
Biolevate is a Paris-based company that assists medical writers in creating documentation for new drugs through its platform. By employing natural language processing (NLP) and visual document reading, it optimizes the creation and management of research and compliance documents. The company's platform acts as an AI assistant, streamlining the often labor-intensive process of medical writing. Biolevate recently gained recognition by being listed among Station F’s Future 40.
Fundz sees it the moment Biolevate raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.